Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-01-13 @ 11:18 PM
Study NCT ID:
NCT04231851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-15
First Post:
2020-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
Sponsor:
University of California, Irvine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-14
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-10
Last Update Post Date:
2025-10-15
Last Update Post Date Type:
ESTIMATED